All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @mitrifit on TikTok · 65s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @mitrifit's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Do you recommend getting the Tesla from Swisscams or what's a credible source you know?
  2. 0:04Modern aminos.com co-metry will save you 10% the website looks like this
  3. 0:09Got SLU MK if you want to waste your money on that Elkharnatine TB-500. Here's the renamed
  4. 0:17GOP's where to true ties now GOP 3RT turns appetite GOP to TZ
  5. 0:23Seema Glutide GOP 1SM there's also a search bar to find everything you could possibly need there
  6. 0:28They got Tesla fan team. They got read a true time. They got SLU. They got five amino injectable and pill. They got KPV
  7. 0:34They got BPC they got everything
  8. 0:36So if you need a credible source use there
  9. 0:38They have just a regular credit card processor the IDM where you don't have to do the verification or they have one
  10. 0:44Where you could use Apple pay but have to verify your ID to make sure it's not a scam
  11. 0:48code me sure to save you 10% on all orders and DM me your order numbers, please
  12. 0:53Just because something's been wrong
  13. 0:55So if you do happen to order and use my code or you have ordered in the past like two to three days
  14. 0:59And if you use my code DM it to me because something's been fishy. So love y'all. Thank you guys for all the support

@mitrifit's peptide therapy claims need context

IFBB Mitri

TikTok creator

200.5K viewsWatch on TikTok

Quick answer

The creator promotes a gray-market peptide vendor carrying compounds including BPC-157, TB-500, KPV, MK-677, and what appear to be semaglutide and tirzepatide analogs sold under obfuscated SKU names, all without any mention of prescriber oversight, purity testing, or regulatory compliance. Several of the listed compounds, particularly MK-677 and GLP-1 analogs, are either banned from compounding or require a valid prescription under US law. The "credible source" framing is not supported by any verifiable regulatory standing.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 10 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @mitrifit's peptide therapy claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

@mitrifit's peptide therapy claims need context should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@mitrifit's peptide therapy claims need context" from IFBB Mitri. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator promotes a gray-market peptide vendor carrying compounds including BPC-157, TB-500, KPV, MK-677, and what appear to be semaglutide and tirzepatide analogs sold under obfuscated SKU names, all without any mention of prescriber oversight, purity testing, or regulatory compliance.

The reason this review is not generic is the source wording and the canonical claim label "peptides replying to mindfulbicks best in the business." In this clip, the useful excerpt is: "Do you recommend getting the Tesla from Swisscams or what's a credible source you know?" That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

A 2022 JAMA analysis found compounded semaglutide products varied significantly from labeled concentrations, posing real overdose and underdose risks.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator promotes a gray-market peptide vendor carrying compounds including BPC-157, TB-500, KPV, MK-677, and what appear to be semaglutide and tirzepatide analogs sold under obfuscated SKU names, all without any mention of prescriber oversight, purity testing, or regulatory compliance.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator promotes a gray-market peptide vendor carrying compounds including BPC-157, TB-500, KPV, MK-677, and what appear to be semaglutide and tirzepatide analogs sold under obfuscated SKU names, all without any mention of prescriber oversight, purity testing, or regulatory compliance. Several of the listed compounds, particularly MK-677 and GLP-1 analogs, are either banned from compounding or require a valid prescription under US law. The "credible source" framing is not supported by any verifiable regulatory standing.
  • MK-677 was removed from the FDA's 503A bulk substances list in 2023, meaning licensed compounding pharmacies can no longer legally produce it for human use.
  • A 2022 JAMA analysis found compounded semaglutide products varied significantly from labeled concentrations, posing real overdose and underdose risks.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • MK-677 was removed from the FDA's 503A bulk substances list in 2023, meaning licensed compounding pharmacies can no longer legally produce it for human use.
  • A 2022 JAMA analysis found compounded semaglutide products varied significantly from labeled concentrations, posing real overdose and underdose risks.
  • BPC-157 and TB-500 have preclinical tissue-repair data (Sikiric et al., 2018; Sosne et al., 2010) but zero FDA-approved human formulations exist in the US.
  • Purchasing GLP-1 analogs like semaglutide or tirzepatide without a prescription violates federal law, regardless of how the vendor labels or names the product.
  • A discount code and a social media DM are not substitutes for a pharmacist, a certificate of analysis, or a licensed prescriber.
  • KPV has anti-inflammatory preclinical data (Catania et al., 2004, Peptides) but has not completed human clinical trials and is not FDA-approved.
  • Consumers buying injectable peptides from unregulated vendors have no recourse if products are contaminated, mislabeled, or cause adverse events.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @mitrifit actually say?

The creator recommended Modern Aminos as a peptide supplier, offered a 10% discount code, and listed available compounds including TB-500, BPC-157, semaglutide analogs, KPV, MK-677, and injectable amino products. They also flagged something "fishy" with recent orders and asked buyers to DM order numbers. This is, at its core, an affiliate promotion for an unregulated peptide vendor.

The creator name-drops compounds like "GOP 3RT," "GOP 2TZ," and "1SM" which appear to be vendor-specific internal naming conventions for GLP-1 receptor agonist analogs, likely tirzepatide and semaglutide derivatives. They also mention "Tesla" which is a vendor SKU, not a standard compound name. Most viewers will not know what they are actually ordering.

Does the science back this up?

Some of the compounds mentioned have legitimate research behind them. The problem is not the molecules. The problem is the source and the framing. Research-grade peptides sold by gray-market vendors are not the same as clinically produced, quality-controlled compounds, and calling any of these suppliers "credible" without regulatory standing is a stretch.

BPC-157 has shown tissue repair activity in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), and TB-500 (Thymosin Beta-4) has wound-healing research behind it (Sosne et al., 2010, Cornea). KPV has demonstrated anti-inflammatory properties in preclinical work (Catania et al., 2004, Peptides). But none of these are FDA-approved for human use in the forms being sold here. MK-677, an oral ghrelin mimetic, has been studied for GH secretion (Nass et al., 2008, Journal of Clinical Endocrinology and Metabolism), but it is also on the FDA's list of compounds withdrawn from the compounding market.

What did they get wrong (or right)?

The creator got one thing right: pointing out that some payment processors require ID verification is accurate. Vendors in this space do use different processors for compliance reasons, and that nuance is real.

Everything else is a problem. Calling an unregistered peptide vendor a "credible source" is misleading. Credibility in a medical context means regulatory oversight, third-party testing, good manufacturing practice certification, and prescriber involvement. Modern Aminos has none of those in a verifiable public form. The creator also lists what appear to be tirzepatide and semaglutide analogs under obfuscated names like "GOP 3RT" and "GOP 2TZ." Selling GLP-1 analogs without a prescription is illegal in the United States. Framing that sale as routine and accessible to anyone with a discount code is not just misleading. It is potentially dangerous. Dosing errors with semaglutide analogs cause serious adverse events including pancreatitis and severe GI distress (FDA Drug Safety Communication, 2023).

What should you actually know?

If you are considering any of the compounds mentioned here, the vendor relationship matters as much as the molecule. Peptides purchased from gray-market sources have no guaranteed purity, concentration accuracy, or sterility. A 2022 analysis published in JAMA found that compounded semaglutide products varied significantly from labeled concentrations, raising real safety flags.

A legitimate telehealth path exists for many of these compounds. BPC-157, KPV, and some growth hormone secretagogues can be prescribed and dispensed through FDA-registered 503A or 503B compounding pharmacies with a licensed provider overseeing dosing and indication. That is not what this video describes. What this video describes is a discount code and a DM request, which should tell you everything you need to know about the oversight involved.

  • No FDA-approved injectable BPC-157 or TB-500 product exists for human use in the US.
  • MK-677 was removed from the FDA bulk substances list for compounding in 2023.
  • GLP-1 analog purchases without a prescription violate federal law regardless of vendor framing.
  • "Something's been fishy" with orders is not a quality control system.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

IFBB Mitri · TikTok creator

200.5K views on this video

Replying to @mindfulbicks best in the business

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about mk-677 was removed from the fda's 503a bulk substances list?

MK-677 was removed from the FDA's 503A bulk substances list in 2023, meaning licensed compounding pharmacies can no longer legally produce it for human use.

What does the video say about a 2022 jama analysis found compounded semaglutide products varied significantly?

A 2022 JAMA analysis found compounded semaglutide products varied significantly from labeled concentrations, posing real overdose and underdose risks.

What does the video say about bpc-157?

BPC-157 and TB-500 have preclinical tissue-repair data (Sikiric et al., 2018; Sosne et al., 2010) but zero FDA-approved human formulations exist in the US.

What does the video say about purchasing glp-1 analogs like semaglutide?

Purchasing GLP-1 analogs like semaglutide or tirzepatide without a prescription violates federal law, regardless of how the vendor labels or names the product.

What does the video say about a discount code?

A discount code and a social media DM are not substitutes for a pharmacist, a certificate of analysis, or a licensed prescriber.

What does the video say about kpv has anti-inflammatory preclinical data (catania et al., 2004, peptides)?

KPV has anti-inflammatory preclinical data (Catania et al., 2004, Peptides) but has not completed human clinical trials and is not FDA-approved.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by IFBB Mitri, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.